Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Arch Oncology
2000 Sierra Point Parkway, Suite 700
Brisbane, CA 94005
Phone: 650-823-2704
https://archoncology.com/

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. The Company\'s next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class. Arch Oncology\'s lead product candidate AO-176 is in a Phase 1 clinical trial for the treatment of patients with select solid tumors. In addition, the Company is advancing a number of pipeline programs, including anti-signal regulatory protein (SIRP) antibodies.

Key Contact
Name
Laurence Blumberg
Title
CEO
Funding Events

Date
Amount
Type
Investors
03/25/19 $50,000,000 Series B 3x5 Partners
Lightchain
RiverVest Venture Partners
Roche Venture Fund
04/28/21 $105,000,000 Series C 3x5 Partners
Adage Capital Management
Avego Bioscience Capital
Broadfin Holdings
Cowen Healthcare Investments
Eventide Asset Management
FMB Research
Lightchain
Point72 Asset Management
RiverVest Venture Partners
Roche Venture Fund